Ardena Signs Agreement to Expand US Footprint with the …
Ghent, Belgium, 14 th October 2024. Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey.
Ardena Signs Agreement to Expand US Footprint with the …
6 days ago · Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical ...
Catalent sells New Jersey production plant, HQ to Belgium's Ardena
6 days ago · Catalent is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey, to Belgium’s Ardena for an undisclosed sum. The transaction is expected to close ...
Ardena Signs Agreement to Expand US Footprint with the
6 days ago · Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the...
Ardena Agrees to Acquire Catalent’s Somerset, NJ Facility
Oct 14, 2024 · Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, NJ.
Ardena appoints Jeremie Trochu as Chief Executive Officer
Ghent, Belgium – Ardena (the “Company”) today announces the retirement of Harry Christiaens, PhD and the subsequent appointment of Jeremie Trochu as Chief Executive Officer. Jeremie is a seasoned executive in the pharmaceutical Contract Development and Manufacturing Operations (CDMO) industry.
Catalent to sell New Jersey facility - MSN
Catalent and Ardena did not disclose financial terms of the deal, which is expected to close in early 2025. Ardena, a provider of drug development services, said the facility will help boost its ...
Ardena’s Nanomedicines Facility Marks €20 Million Expansion …
Ardena’s Nanomedicines Facility Marks €20 Million Expansion with first GMP approval. Oss, The Netherlands — Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new ...
Ardena News | Ardena Insights | Ardena pharma
Mar 6, 2024 · Keep up to date with the latest news and insights from Ardena so that you never miss any developments in Ardena's journey.
Ardena Signs Agreement To Expand US Footprint With The …
Oct 14, 2024 · Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey. ... News | October 14, 2024